Literature DB >> 1600329

Autoimmune hemolytic anemia combined with idiopathic thrombocytopenia (Evans syndrome). Sustained remission in a patient following high-dose intravenous gamma-globulin therapy.

P E Petrides1, E Hiller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600329     DOI: 10.1007/bf00422936

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


× No keyword cloud information.
  5 in total

1.  Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.

Authors:  G Dietrich; M D Kazatchkine
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Effect of intravenous immunoglobulin in immune thrombocytopenia.

Authors:  A Salama; C Mueller-Eckhardt; V Kiefel
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

3.  Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia.

Authors:  M W Hilgartner; J Bussel
Journal:  Am J Med       Date:  1987-10-23       Impact factor: 4.965

4.  Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

Authors:  J Fehr; V Hofmann; U Kappeler
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

5.  High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome).

Authors:  H Oda; A Honda; K Sugita; A Nakamura; H Nakajima
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

  5 in total
  2 in total

1.  The spectrum of Evans' syndrome.

Authors:  S Savaşan; I Warrier; Y Ravindranath
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

2.  Clinical applications of immunoglobulin: update.

Authors:  Marcia Cristina Zago Novaretti; Carla Luana Dinardo
Journal:  Rev Bras Hematol Hemoter       Date:  2011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.